← Leaderboards
Stewart Cooper
Northern California Institute Res &Educ
$7,173,885
Attributed
$14,255,752
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,255,752 · 3
By mechanism
R01$9,052,592 · 2
U01$5,203,160 · 1
Top collaborators
- Jody L Baron10 shared
- Mandana Khalili6 shared
- Norah A. Terrault6 shared
Others in their field
Top investigators on “Hepatitis B”
- Constance Ann Benson · University Of California, San Diego$185,164,833
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$152,807,032
- Judith S. Currier · University Of California Los Angeles$150,849,200
- Sharon A Nachman · Johns Hopkins University$116,445,585
- Grace M. Aldrovandi · University Of California Los Angeles$48,781,697
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$48,011,901
Research focus
Hepatitis BCirrhosisImmune ResponseLiver BiopsyLiver FailureSan FranciscoImmunologicsAnalogUniversitiesCessation Of LifeLiver DiseasesChronic Hepatitis BHepatitis B E AntigensPrimary Carcinoma Of The Liver CellsTissuesHepatitis B Surface AntigensAftercareAntiviral TherapyBaseClinical ResearchHepatitis B VirusProspective StudiesCellsImmunity
Grant awards (22)
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$723,268
R01 · FY2025 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$686,488
R01 · FY2024 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$718,565
R01 · FY2023 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$727,689
R01 · FY2022 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$762,427
R01 · FY2021 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$682,265
R01 · FY2020 · DK · contact PI
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$742,927
U01 · FY2019 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$699,003
R01 · FY2019 · DK · contact PI
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$164,266
U01 · FY2019 · DK
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$1,361,363
U01 · FY2018 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$707,841
R01 · FY2018 · DK · contact PI
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$1,018,572
U01 · FY2017 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$723,189
R01 · FY2017 · DK · contact PI
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$1,031,384
U01 · FY2016 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$795,453
R01 · FY2016 · DK · contact PI
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies$884,648
U01 · FY2015 · DK
Immune Responses in Acute Hepatitis C$346,967
R01 · FY2007 · DK · contact PI
Immune Responses in Acute Hepatitis C$357,330
R01 · FY2006 · DK · contact PI
Immune Responses in Acute Hepatitis C$365,928
R01 · FY2005 · DK
The Melanocortin-4 Receptor in Human Obesity$244,134
R01 · FY2004 · DK
The Melanocortin-4 Receptor in Human Obesity$138,976
R01 · FY2004 · DK
Immune Responses in Acute Hepatitis C$373,069
R01 · FY2003 · DK